Kato N - Search Results

1

The risk of persistent carriage of methicillin-resistant Staphylococcus aureus in hematopoietic stem cell transplantation.

Kato N, Tanaka J, Mori A, Tutumi Y, Yonezumi M, Chiba K, Kondo T, Toyoshima N, Ota S, Hashino S, Asaka M, Imamura M. Kato N, et al. Ann Hematol. 2003 May;82(5):310-2. doi: 10.1007/s00277-003-0626-0. Epub 2003 Apr 23. Ann Hematol. 2003. PMID: 12709827

2

Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia.

Arita K, Kondo T, Sugita J, Shigematsu A, Shiratori S, Wakasa K, Yasumoto A, Ibata M, Shono Y, Kikuchi M, Goto H, Takeda Y, Takahata M, Kato N, Nishio M, Ota S, Tanaka J, Imamura M. Arita K, et al. Among authors: kato n. Int J Hematol. 2011 Sep;94(3):291-295. doi: 10.1007/s12185-011-0919-3. Epub 2011 Aug 31. Int J Hematol. 2011. PMID: 21879292 Free article.

3

Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.

Toubai T, Shono Y, Nishihira J, Ibata M, Suigita J, Kato N, Ohkawara T, Tone S, Lowler KP, Ota S, Tanaka J, Asaka M, Reddy P, Imamura M. Toubai T, et al. Among authors: kato n. Int J Lab Hematol. 2009 Apr;31(2):161-8. doi: 10.1111/j.1751-553X.2007.01016.x. Epub 2007 Dec 12. Int J Lab Hematol. 2009. PMID: 18081874 Free article.

4

Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma.

Toubai T, Hirate D, Shono Y, Ota S, Ibata M, Mashiko S, Sugita J, Shigematsu A, Miura Y, Kato N, Umehara S, Kahata K, Tsutsumi Y, Iwao N, Toyoshima N, Tanaka J, Asaka M, Imamura M. Toubai T, et al. Among authors: kato n. Int J Lab Hematol. 2008 Feb;30(1):75-81. doi: 10.1111/j.1751-553X.2007.00903.x. Int J Lab Hematol. 2008. PMID: 18190473

5

Analysis of T-cell repertoire and mixed chimaerism in a patient with aplastic anaemia after allogeneic bone marrow transplantation.

Tsutsumi Y, Tanaka J, Sugita J, Kato N, Zhang L, Yonezumi M, Chiba K, Toyosima N, Kondo T, Ohta S, Mori A, Hasino S, Asaka M, Imamura M. Tsutsumi Y, et al. Among authors: kato n. Br J Haematol. 2002 Jul;118(1):136-9. doi: 10.1046/j.1365-2141.2002.03628.x. Br J Haematol. 2002. PMID: 12100138 Free article.

6

Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation.

Tsutsumi Y, Tanaka J, Miura Y, Toubai T, Kato N, Fujisaw F, Toyoshima N, Ota S, Mori A, Yonezumi M, Chiba K, Kondo T, Hasino S, Kobayasi R, Masauji N, Kasai M, Asaka M, Imamura M. Tsutsumi Y, et al. Among authors: kato n. Leuk Lymphoma. 2004 Mar;45(3):481-8. doi: 10.1080/10428190310001609898. Leuk Lymphoma. 2004. PMID: 15160909

7

Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.

Toubai T, Tanaka J, Mori A, Hashino S, Kobayashi S, Ota S, Miura Y, Kato N, Kahata K, Izumiyama K, Yonezumi M, Chiba K, Kondo T, Toyoshima N, Asaka M, Imamura M. Toubai T, et al. Among authors: kato n. Clin Transplant. 2004 Oct;18(5):552-7. doi: 10.1111/j.1399-0012.2004.00225.x. Clin Transplant. 2004. PMID: 15344959

8

Successful reduced-intensity stem cell transplantation (RIST) for a patient with malignant lymphoma and an ileostomy.

Toubai T, Tanaka J, Ota S, Mori A, Ibata M, Shono Y, Mashiko S, Sugita J, Miura Y, Kato N, Umehara S, Kahata K, Toyoshima N, Asaka M, Imamura M. Toubai T, et al. Among authors: kato n. Intern Med. 2005 May;44(5):476-9. doi: 10.2169/internalmedicine.44.476. Intern Med. 2005. PMID: 15942098 Free article.

9

[Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].

Toubai T, Tanaka J, Ota S, Kato N, Umehara S, Kahata K, Toyoshima N, Asaka M, Imamura M. Toubai T, et al. Among authors: kato n. Jpn J Antibiot. 2005 Dec;58(6):507-17. Jpn J Antibiot. 2005. PMID: 16521343 Japanese.

10

Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.

Tanaka J, Sugita J, Kato N, Toubai T, Ibata M, Shono Y, Ota S, Kondo T, Kobayashi T, Kobayashi M, Asaka M, Imamura M. Tanaka J, et al. Among authors: kato n. Exp Hematol. 2007 Oct;35(10):1562-6. doi: 10.1016/j.exphem.2007.06.006. Epub 2007 Aug 2. Exp Hematol. 2007. PMID: 17681668 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,957 results

Search Page

Filters